{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:49:32Z","timestamp":1775742572527,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037239","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T21:13:34Z","timestamp":1337116414000},"page":"e37239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma"],"prefix":"10.1371","volume":"7","author":[{"given":"Ivaylo","family":"Gentschev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Adelfinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Josupeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas","family":"Ehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Donat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanhai G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong A.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Heisig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Thamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Stritzker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aladar A.","family":"Szalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"key":"ref1","first-page":"425","article-title":"Soft tissue sarcomas.","year":"2007"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1939-1676.2000.tb02279.x","article-title":"Postoperative radiotherapy for canine soft tissue sarcoma.","volume":"14","author":"LJ Forrest","year":"2000","journal-title":"J Vet Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1748-5827.2002.tb00066.x","article-title":"Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs.","volume":"43","author":"JM Dobson","year":"2002","journal-title":"J Small Anim Pract"},{"key":"ref4","first-page":"307","article-title":"Epidemiology of canine and feline tumors.","volume":"12","author":"ER Dorn","year":"1976","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref5","article-title":"Tumors of skin and subcutaneous tissues.","year":"1979"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0300985810388820","article-title":"Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.","volume":"48","author":"MM Dennis","year":"2011","journal-title":"Vet Pathol"},{"key":"ref7","first-page":"173","article-title":"Soft-tissue sarcomas.","volume":"10","author":"DE Thrall","year":"1995","journal-title":"Semin Vet Med Surg (Small Anim)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910330108","article-title":"Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.","volume":"33","author":"M Trojani","year":"1984","journal-title":"Int J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2460\/javma.1997.211.09.1147","article-title":"Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986\u20131996).","volume":"211","author":"CA Kuntz","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1354\/vp.08-VP-0277-M-FL","article-title":"Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.","volume":"46","author":"KD McSporran","year":"2009","journal-title":"Vet Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2460\/javma.2000.217.205","article-title":"Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.","volume":"217","author":"JA McKnight","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world's first oncolytic virus therapy for cancer treatment.","volume":"98","author":"K Garber","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1158\/0008-5472.CAN-07-0146","article-title":"Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.","volume":"67","author":"Q Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00438-009-0475-1","article-title":"The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.","volume":"282","author":"Q Zhang","year":"2009","journal-title":"Mol Genet Genomics"},{"key":"ref15","article-title":"Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.","volume":"976\u2013983","author":"SF Lin","year":"2007","journal-title":"Surgery 142: 976\u2013983; discussion"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1210\/jc.2008-0316","article-title":"Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.","volume":"93","author":"SF Lin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/hum.2008.036","article-title":"Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.","volume":"19","author":"KJ Kelly","year":"2008","journal-title":"Hum Gene Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1535-7163.MCT-08-0533","article-title":"Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.","volume":"8","author":"YA Yu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e22069","DOI":"10.1371\/journal.pone.0022069","article-title":"Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.","volume":"6","author":"I Gentschev","year":"2011","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/489759","article-title":"Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.","author":"I Gentschev","year":"2010"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1476-4598-8-45","article-title":"Oncolytic vaccinia viral therapy of squamous cell carcinoma.","volume":"8","author":"Z Yu","year":"2009","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/cgt.2008.87","article-title":"Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.","volume":"16","author":"I Gentschev","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/736907","article-title":"Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.","author":"I Gentschev","year":"2010"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0300985810383871","article-title":"Establishment and characterization of a canine soft tissue sarcoma cell line.","volume":"48","author":"SA Snyder","year":"2011","journal-title":"Vet Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/1040638711408064","article-title":"Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation.","volume":"23","author":"LE O'Donoghue","year":"2011","journal-title":"J Vet Diagn Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1462-5822.2008.01122.x","article-title":"Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment.","volume":"10","author":"S Weibel","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities.","volume":"6","author":"C Nathan","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1525-0016(02)00049-7","article-title":"A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model.","volume":"7","author":"A Hemminki","year":"2003","journal-title":"Mol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1078-0432.CCR-04-1944","article-title":"In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.","volume":"11","author":"SE Suter","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1476-5829.2009.00187.x","article-title":"Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks.","volume":"7","author":"M Arendt","year":"2009","journal-title":"Vet Comp Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-10-3","article-title":"Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.","volume":"10","author":"SS Patil","year":"2012","journal-title":"J Transl Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2407-11-68","article-title":"Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.","volume":"11","author":"S Weibel","year":"2011","journal-title":"BMC Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1479-5876-9-164","article-title":"Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.","volume":"9","author":"NG Chen","year":"2011","journal-title":"J Transl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow.","volume":"15","author":"CJ Breitbach","year":"2007","journal-title":"Mol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/hum.2009.135","article-title":"The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.","volume":"20","author":"RJ Prestwich","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.24037","article-title":"Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model.","volume":"124","author":"KJ Kelly","year":"2009","journal-title":"Int J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/cgt.2010.49","article-title":"Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a beta-galactosidase-activatable prodrug seco-analog of duocarmycin SA.","volume":"18","author":"CM Seubert","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/bjc.2011.429","article-title":"Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.","volume":"105","author":"M Gil","year":"2011","journal-title":"Br J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor-associated neutrophils: new targets for cancer therapy.","volume":"71","author":"AD Gregory","year":"2011","journal-title":"Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN.","volume":"16","author":"ZG Fridlender","year":"2009","journal-title":"Cancer Cell"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:31:38Z","timestamp":1743132698000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037239"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}